News
For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a ...
7h
ScienceAlert on MSNScientists May Have Identified a Natural Alternative to Ozempic
Glucagon-like peptide-1 (GLP-1) is a hormone that is naturally produced by the body and which helps regulate blood sugar ...
3h
HealthDay on MSNGLP-1 Receptor Agonists May Reduce Complications of Diabetic Retinopathy
For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a ...
19h
News-Medical.Net on MSNBrain’s energy control map offers blueprint for next-gen weight loss therapies
Scientists map how the brain integrates hormonal and neural signals from the body to control appetite, energy use, and reward ...
Accepting the bioequivalence study report, the Subject Expert Committee (SEC) functional under the Central Drugs Standard ...
(HealthDay News) — A considerable proportion of adolescents and young adults eligible for glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are uninsured, and many young adults do not have a ...
Researchers at Syracuse University have identified a brain peptide, TDN, that effectively curbs appetite and enhances glucose ...
The new targeted pipeline will advance Nxera’s oral GLP-1 agonists, novel GPCR targets, and structure-based drug design to ...
Prices for Indian consumers are expected to come down significantly from the current Rs 17,000-Rs 26,000 monthly.
Data suggests that some sectors of Europe's confectionery sector are declining. Could GLP-1s have a role to play in this?
Fat jabs could soon be available over the counter at pharmacies without the need for a GP, according to rppeorts. Fat jabs ...
A UK government and Eli Lilly £85 million program will expand obesity care nationwide, offering digital, community, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results